Blog
RSS FeedPosted by Michael Wonder on 17 Sep 2018
Patients with high-risk skin cancer have new treatment option
17 September 2018 - Hundreds of patients with a type of advanced skin cancer are set to benefit from a new ...
Posted by Michael Wonder on 14 Sep 2018
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...
Posted by Michael Wonder on 14 Sep 2018
Blood cancer drugs added to PBS
14 September 2018 - The Federal Government is spending $48 million to provide more affordable drugs for Australians with blood ...
Posted by Michael Wonder on 13 Sep 2018
PHARMAC defends position not to fund bowel cancer drug
14 September 2018 - PHARMAC is defending its position to not fund a drug recommended to patients with late-stage bowel cancer ...
Posted by Michael Wonder on 13 Sep 2018
Dying cancer patients refused PHARMAC funding
13 September 2018 - Dying patients who suffer a rare reaction to chemotherapy are having to pay for their own ...
Posted by Michael Wonder on 13 Sep 2018
DoH moves to ensure equal access to cancer drugs in Northern Ireland
13 September 2018 - The Department of Health in Northern Ireland has unveiled plans to boost access to innovative new ...
Posted by Michael Wonder on 12 Sep 2018
A breakthrough cancer drug has been approved. Now comes the battle over the price.
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
Posted by Michael Wonder on 12 Sep 2018
Battle for wonder drug pays off
13 September 2018 - A West Pymble mother feels the “weight of the world” has been lifted following the federal ...
Posted by Michael Wonder on 12 Sep 2018
In Australia, NovaTears eye drops are available on the Pharmaceutical Benefits Scheme
12 September 2018 - Using innovative new technology, NovaTears effectively establishes a new class of treatment for evaporative dry eye. ...
Posted by Michael Wonder on 12 Sep 2018
Decision to list nintedanib (Ofev) and remove restrictions from tiotropium bromide (Spiriva)
12 September 2018 - PHARMAC is pleased to announce a decision to list nintedanib (Ofev) and remove the current Special ...
Posted by Michael Wonder on 11 Sep 2018
ABPI hits out at ‘punitive’ UK medicines cost controls
11 September 2018 - Steep rise in charges an 'alarming signal' amid Brexit uncertainty ...
Posted by Michael Wonder on 11 Sep 2018
Health secretary’s ‘rip off’ remarks anger UK pharma
11 September 2018 - Row with Vertex has tainted government-industry relations. ...
Posted by Michael Wonder on 11 Sep 2018
Scotland could be 'world leader' in precision medicine, says First Minister
9 September 2018 - Scotland has the potential to be a "world leader" in precision medicine, according to the first ...
Posted by Michael Wonder on 11 Sep 2018
Health fund reforms: Parliament passes drastic changes, here is what they mean
11 September 2018 - Health funds will be able to close down your health fund policy and shift you to ...
Posted by Michael Wonder on 10 Sep 2018
NICE turns down Opdivo for adjuvant melanoma therapy
10 September 2018 - BMS drug currently only licensed treatment in this setting. ...